학술논문

Quality of Life in Patients with Irritable Bowel Syndrome (IBS), Assessed Using the IBS–Quality of Life (IBS-QOL) Measure After 4 and 8 Weeks of Treatment with Mebeverine Hydrochloride or Pinaverium Bromide: Results of an International Prospective Observational Cohort Study in Poland, Egypt, Mexico and China
Document Type
Article
Source
In: Clinical Drug Investigation. (Clinical Drug Investigation, 1 November 2014, 34(11):783-793)
Subject
Language
English
ISSN
11791918
11732563